title: Hepatitis E virus in Cuba.
abstract: The hepatitis E virus (HEV) has a global distribution and is known to have caused large waterborne epidemics of icteric hepatitis. The transmission is primarily fecal-oral. Some reports have suggested parenteral transmission of HEV from its association to hepatitis B or hepatitis C infection, or due to the development of hepatitis E after blood transfusion. Though most of the developing countries in Asia and Africa have been shown to be endemic for HEV infection, studies in the Latin American countries have been limited to Mexico, Brazil and Venezuela. We have developed an enzyme immunoassay (EIA) for IgM and IgG antibodies to a recombinant protein containing antigenic epitopes of the ORF3 region of the HEV. This system, as well as a commercial kit that includes ORF2 and ORF3 antigenic epitopes, were used to study the prevalence of anti-HEV antibodies in a sample of Cuban blood donors, acute hepatitis cases and individuals subjected to plasmapheresis. The incidence of anti-HEV IgM was compared with other viral hepatitis markers. Our findings suggest that infections due to HEV are an important viral cause of sporadic hepatitis in Cuba, and that HEV is endemic to this region of the world.
authors.affiliation: Division of Immunotechnology and Diagnostics, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
authors.forename: G
authors.initials: G
authors.lastname: Lemos
authors.forename: S
authors.initials: S
authors.lastname: Jameel
authors.forename: S
authors.initials: S
authors.lastname: Panda
authors.forename: L
authors.initials: L
authors.lastname: Rivera
authors.forename: L
authors.initials: L
authors.lastname: Rodríguez
authors.forename: J V
authors.initials: JV
authors.lastname: Gavilondo
mesh_terms: D000328:Adult; D003462:Cuba / Q000453:epidemiology; D019353:Endemic Diseases; D006508:Hepatitis Antibodies / Q000097:blood*; D018963:Hepatitis Antigens / Q000235:genetics / Q000276:immunology; D016751:Hepatitis E / Q000175:diagnosis / Q000453:epidemiology*; D016752:Hepatitis E virus / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques; D015994:Incidence; D016366:Open Reading Frames; D015995:Prevalence; D011994:Recombinant Proteins / Q000276:immunology
chemical_list: D006508:Hepatitis Antibodies; D018963:Hepatitis Antigens; D011994:Recombinant Proteins